
ORLY · Nasdaq
Consensus is Buy across 23 analysts, with a mean price target of $110; the supplied data provide neither a low nor a high target, so target clustering and dispersion cannot be measured. No named analyst or firm is identified as most or least bullish, and no target or rating revisions are reported for the past week. The substantive disagreement therefore cannot be attributed to specific analysts or quantified target assumptions. The available evidence instead shows a uniformly positive aggregate stance alongside a Q2 earnings beat, 6% comparable-store-sales growth, 10% diluted-EPS growth, professional-customer momentum, and an improved 2026 outlook.